Nov 13, 2020, 11:24 by

Software will enhance research oversight, improve transparency and expedite veterans’ access to clinical trials for more than 100 VA medical centers that have research programs

Nov 13, 2020, 11:24 by

Rho Federal Systems Division, Inc. Awarded Statistical and Data Coordinating Center Contract in BARDA Medical Countermeasures Clinical Studies Network CRO will serve to standardize data collection, management, and analysis across BARDA-supported network studies. Research Triangle Park, NC – November 9, 2020 – Rho, a full-service contract research organization (CRO) that helps pharmaceutical and biotechnology companies bring their products to market through high-quality clinical research services, announces the Rho Federal Systems Division, Inc. (RhoFED) was awarded a contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services to manage a Statistical and Data Coordinating Center (SDCC) for BARDA’s Medical Countermeasures Clinical Studies Network. Under the contract, RhoFED will be responsible for standardizing data collection, management, and analysis across BARDA-supported network studies.

Nov 13, 2020, 11:24 by

Shimmer’s wearable sensor is now recognized as a medical device in Europe, capable of providing continuous, medical-grade measurements of a person’s activity.

Nov 13, 2020, 11:24 by

SCORR Marketing, a global health science marketing and communications firm, has released its eighth annual survey report, Marketing Trends in Health Science Services Companies. The report is free and features data that health science executives and marketers can use to understand how companies are approaching marketing in the midst of the COVID-19 pandemic. The report provides valuable insights that can guide strategic planning, budgeting, and tactics in the year ahead.

Nov 13, 2020, 11:24 by

GT Medical Technologies, Inc., a company dedicated to improving the lives of patients with brain tumors, today announced the first patient has been enrolled into its registry trial of GammaTile®, a FDA-cleared, Surgically Targeted Radiation Therapy (STaRT) for newly diagnosed malignant and recurrent brain tumors. The study will evaluate the safety and effectiveness of GammaTile Therapy in a real-world setting in up to 50 brain tumor centers across the United States.

Nov 13, 2020, 11:24 by

Annual event by eClinical goes virtual on November 18-19 to highlight digital transformation of life sciences

Nov 13, 2020, 11:24 by

Isohelix announces its state-of-the-art GeneFiX™ Saliva RNA Collection Device is the technology of choice for COVID-19 testing by Precision Genetics. The high-performance, easy-to-use device marks the latest addition to Precision Genetics’ extensive portfolio of validated COVID-19 testing options submitted under the U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA).

Nov 13, 2020, 11:24 by

Pioneering research conducted by the University of Virginia in collaboration with APIS Assay Technologies has discovered Hormone-Upregulated lncRNA within lymphocyte-specific protein tyrosine kinase is detectable in non-invasive prostate cancer patient samples. The breakthrough data provides a potential new approach to address the unmet medical need of early diagnostics for prostate cancer, in combination with avoiding the invasive cancer tissue sample collection from a biopsy.

Nov 13, 2020, 11:24 by

Australian clinical-stage drug development company Noxopharm (ASX: NOX) is pleased to announce it has joined with Bristol Myers Squibb (NYSE: BMY) in an Australian pilot study investigating the ability of Noxopharm’s immunotherapy drug candidate, Veyonda®, to overcome resistance to Bristol Myers Squibb’s nivolumab (Opdivo®) in the treatment of cancer.

Nov 13, 2020, 11:24 by

Pill Connect, formerly known as Elucid mHealth, has completed a £510,000 funding round to complete development of the design, electronics and software for submission to the regulatory authorities in both Europe and the US and continue through to commercial launch.

Nov 13, 2020, 01:01 by User Not Found

Clinical Research News | Italian insights into re-infection, Oxford studies increased rates of psychiatric diagnoses, a model for how today’s nonpharmaceutical interventions will impact future flu seasons, exploring the relationship between ethnicity and clinical outcomes, and tracking COVID-19 research over time. Plus, a recommended vaccine distribution framework and new funding for Canadian treatments and vaccines.

Nov 10, 2020, 01:00 by User Not Found

Clinical Research News | New products, collaborations and deployments from the past two months from Medable, Thermo Fisher, Seqster, Takeda, Medidata, Caris Life Sciences, Oracle, Lyft, Elsevier, and more.

Nov 6, 2020, 11:55 by User Not Found

Clinical Research News I Statin treatment may prevent deaths, COVID-19 worsens tinnitus, delirium early symptom in elderly, monoclonal antibody LY-CoV555 reduces hospitalization, phase 3 trial underway for REGN-COV2 antibody cocktail, remdesivir shows no mortality benefit, pandemic effects on childbirth, seven forms of disease identified, twenty percent experience GI symptoms, osteoporosis drugs may offer protection, and Europe linked to spread. Plus: Skin symptoms reveal ‘long haulers’, autoimmune antibody culprit for blood clots, smartphone app to reach at risk communities, increased discrimination against Asian Americans affecting their health, and smartwatch predicts COVID-19 infection.

Nov 4, 2020, 12:47 by User Not Found

Clinical Research News | The current pandemic has necessitated a drastic shift for remote site access in clinical trials, leading to a flood of technology vendors in the market with solutions to assist sponsors and CROs. Vendors that provide Electronic Investigator Site File (eISF) and Remote Site Access technology solutions are experiencing a mass scramble of sponsors and CROs looking for solutions to support a pivot due to COVID—a pivot to remote processes that is here to stay far beyond the pandemic.

Nov 2, 2020, 15:45 by

Advances include a rapid vaccine analysis platform, companion diagnostic for solid tumors, and bioanalytical validation methods for biomarkers and companion diagnostics

Nov 2, 2020, 15:45 by

As OWEAR embarks on its second year, organizers see potential to expand its positive industry impact beyond the organization’s original mission

Nov 2, 2020, 15:45 by

Protheragen, a company founded in Ronkonkoma, New York, 2009, announces to offer license opportunities for drug R&D companies.

Nov 2, 2020, 15:45 by

On October 24, 2020, AI & Medicine, one of the forerunners in the AI-assisted medicine area, announces it now provides PK/PD modeling service to help scientists and researchers more efficiently screen drugs and thus accelerating the process of new drug development. The company is known as an expert in applying artificial intelligence into drug discovery, personalized healthcare and various other medical applications.

Nov 2, 2020, 15:45 by

The benefits of fluorochemistry to pharmaceutical applications are obvious and the past decades has seen increasing synthesis of fluorinated compounds in the preparation of new pharmaceuticals and agrochemicals. To better meet the growing needs of customers worldwide, the New York-based chemical supplier Alfa Chemistry announced to offer high-purity fluorinated building blocks for various application scenarios such as material, medicine, agriculture and organic chemistry.

Nov 2, 2020, 15:45 by

Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, and All4Cure, which has built a real world data powered network of patients, clinicians and researchers to dramatically improve outcomes for millions of patients with cancer, today announced their partnership. Notable will leverage All4Cure’s network to enhance and expand its functional precision oncology platform.